Novo CEO pressed by Senate to cut prices of being overweight, diabetes medicine CEO Lars Fruergaard Jørgensen told lawmakers the business would consider new talks with insurers in regards to the record prices of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies. Financial https://holdentkaqf.shoutmyblog.com/30104445/5-simple-techniques-for-healthcare-news